SCB-808 (etanercept biosimilar)
/ Sichuan Clover Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 30, 2019
"Clover Biopharmaceuticals Initiates Phase III Study of Etanercept Biosimilar Candidate SCB-808 in China https://t.co/X0yWg0iX7A"
(@NewsFromBW)
1 to 1
Of
1
Go to page
1